Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Array Technologies Inc ARRY

Industrials
Array Technologies, Inc. is a provider of utility-scale solar tracker technology. The Company manufactures ground-mounting tracking systems used in utility and distributed generation solar energy projects worldwide. The Company’s segments include Array Legacy Operations and STI Legacy Operations. Its principal products are a portfolio of integrated solar tracking systems comprised of software... see more

Recent & Breaking News (NDAQ:ARRY)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint on Behalf of Array Biopharma Inc. Shareholders and Lead Plaintiff Deadline of January 22, 2018 – ARRY

GlobeNewswire November 21, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Array BioPharma Inc.

Business Wire November 20, 2017

Array BioPharma Announces Private Exchange of $107 Million of its 3.00% Convertible Senior Notes due 2020 for its 2.625% Convertible Senior Notes due 2024 and Shares of its Common Stock

PR Newswire November 16, 2017

Array BioPharma Reports Initial Results From Novel Immunotherapy Combination At The Society For Immunotherapy Of Cancer (SITC) 32nd Annual Meeting

PR Newswire November 13, 2017

Array BioPharma To Present At The 2017 Stifel Healthcare Conference

PR Newswire November 8, 2017

Factors of Influence in 2018, Key Indicators and Opportunity within AGNC Investment, Discovery Communications, Array BioPharma, Callon Petroleum, People's United, and DDR – New Research Emphasizes Economic Growth

GlobeNewswire November 8, 2017

Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2018

PR Newswire October 31, 2017

Array BioPharma Inc. to Host Earnings Call

Accesswire October 31, 2017

Array Biopharma To Report Financial Results For The First Quarter Of Fiscal 2018 On October 31, 2017

PR Newswire October 24, 2017

Breakfast Technical Briefing on Biotech Stocks -- Amicus Therapeutics, Argos Therapeutics, Array BioPharma, and Aurinia Pharma

PR Newswire September 26, 2017

Array BioPharma To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference

PR Newswire September 19, 2017

Array BioPharma Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares

PR Newswire September 19, 2017

20 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  September 15, 2017

Array BioPharma Announces Pricing of Public Offering of Common Stock

PR Newswire September 14, 2017

12 Biggest Mid-Day Losers For Thursday

Benzinga.com  September 14, 2017

5 Stocks To Watch For September 14, 2017

Benzinga.com  September 14, 2017

Array BioPharma Announces Proposed Public Offering of Common Stock

PR Newswire September 13, 2017

Array BioPharma Announces FDA Acceptance For Review Of Binimetinib And Encorafenib New Drug Applications For Patients With Advanced BRAF-mutant Melanoma

PR Newswire September 12, 2017

18 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  September 11, 2017

Phase 3 COLUMBUS Part 2 Results in BRAF-Mutant Melanoma Presented at European Society for Medical Oncology Congress

PR Newswire September 9, 2017